Investigación

Estudio de enfermedades por disfunción inmune en Pediatría (GEMDIP)

Buscador de publicaciones

Publicaciones

  • Saper VE, Ombrello MJ, Tremoulet AH, Montero-Martin G, Prahalad S, Canna S, Shimizu C, Deutsch G, Tan SY, Remmers EF, Monos D, Hahn T, Phadke OK, Cassidy E, Ferguson I, Mallajosyula V, Xu J, Rosa Duque JS, Chua GT, Ghosh D, Szymanski AM, Rubin D, Burns JC, Tian L, Fernandez-Vina MA, Mellins ED and Hollenbach JA.

    Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles.

    ANNALS OF THE RHEUMATIC DISEASES . 81(3): 406-415. Nº de citas: 61

    [doi:10.1136/annrheumdis-2021-220578]

  • Foeldvari I, Klotsche J, Hinrichs B, Helmus N, Kasapcopur O, Adrovic A, Sztajnbok F, Terreri MT, Anton-Lopez J, Smith V, Katsicas M, Kostik M, Vasquez-Canizares N, Avcin T, Feldman B, Janarthanan M, Santos MJ, Sawhney S, Schonenberg-Meinema D, Sifuentes-Giraldo WA, Alexeeva E, Appenzeller S, Battagliotti C, Berntson L, Bica B, Costa Reis P, Eleftheriou D, Kallinich T, Lehman T, Marrani E, Minden K, Nielsen S, Nuruzzaman F, Patwardhan A, Khubchandani R, Stanevicha V, Uziel Y and Torok KS.

    Underdetection of Interstitial Lung Disease in Juvenile Systemic Sclerosis

    ARTHRITIS CARE & RESEARCH . 74(3): 364-370. Nº de citas: 11

    [doi:10.1002/acr.24499]

  • Zanetti SR, Velasco-Hernandez T, Gutierrez-Agüera F, Díaz VM, Romecín PA, Roca-Ho H, Sánchez-Martínez D, Tirado N, Baroni ML, Petazzi P, Torres-Ruiz R, Molina O, Bataller A, Fuster JL, Ballerini P, Juan-Otero M, Jeremias I, Bueno C and Menéndez P.

    A novel and efficient tandem CD19-and CD22-directed CAR for B cell ALL

    MOLECULAR THERAPY . 30(2): 550-563. Nº de citas: 25

    [doi:10.1016/j.ymthe.2021.08.033]

  • Bustaffa M, Koné-Paut I, Ozen S, Amaryan G, Papadopoulou-Alataki E, Gallizzi R, Carrabba M, Aviel YB, Cantarini L, Alessio M, Anton-Lopez J, Obici L, Gok F, Batu ED, Moreno E, Brogan P, Trachana M, Simonini G, Rigante D, Uziel Y, Insalaco A, Maggio MC, Ruperto N, Gattorno M and Semerano LR.

    The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort

    SEMINARS IN ARTHRITIS AND RHEUMATISM . 52: 151957-151957. Nº de citas: 6

    [doi:10.1016/j.semarthrit.2022.151957]

  • Grasa CD, Fernández-Cooke E, Sánchez-Manubens J, Carazo-Gallego B, Aracil-Santos J, Anton-Lopez J, Lirola MJ, Mercader B, Villalobos E, Bustillo M, Giralt G, Rocandio B, Escribano LM, Domínguez-Rodríguez S and Calvo C.

    Kawasaki disease in children younger than 6 months of age: characteristics of a Spanish cohort

    EUROPEAN JOURNAL OF PEDIATRICS . 181(2): 589-598. Nº de citas: 4

    [doi:10.1007/s00431-021-04215-8]

  • Egg D, Rump IC, Mitsuiki N, Rojas-Restrepo J, Maccari ME, Schwab C, Gabrysch A, Warnatz K, Goldacker S, Patiño V, Wolff D, Okada S, Hayakawa S, Shikama Y, Kanda K, Imai K, Sotomatsu M, Kuwashima M, Kamiya T, Morio T, Matsumoto K, Mori T, Yoshimoto Y, Dybedal I, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Lorenz HM, Sullivan KE, Heimall J, Moutschen M, Litzman J, Recher M, Albert MH, Hauck F, Seneviratne S, Schmid JP, Kolios A, Unglik G, Klemann C, Snapper S, Giulino-Roth L, Svaton M, Platt CD, Hambleton S, Neth O, Gosse G, Reinsch S, Holzinger D, Kim YJ, Bakhtiar S, Atschekzei F, Schmidt R, Sogkas G, Chandrakasan S, Rae W, Derfalvi B, Marquart HV, Ozen A, Kiykim A, Karakoc-Aydiner E, Králícková P, de Bree G, Kiritsi D, Seidel MG, Kobbe R, Dantzer J, Alsina L, Armangue-Salvador T, Lougaris V, Agyeman P, Nyström S, Buchbinder D, Arkwright PD and Grimbacher B.

    Therapeutic options for CTLA-4 insufficiency

    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY . 149(2): 736-746. Nº de citas: 71

    [doi:10.1016/j.jaci.2021.04.039]

  • Girona M, Argüello G, Esteve-Solé A, Bobillo-Perez S, Paolo-Burgos X, Bonet E, Mensa-Vilaró A, Codina-Bergadà A, Hernández-Garcia M, Jou-Munoz C, Alsina L and Jordán-García I.

    Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults

    iScience . 25(1): 103595-103595. Nº de citas: 2

    [doi:10.1016/j.isci.2021.103595]

  • Santamaria M, Neth O, Douglass JA, Krivan G, Kobbe R, Bernatowska E, Grigoriadou S, Bethune C, Chandra A, Horneff G, Borte M, Sonnenschein A, Kralickova P, Ramón SS, Langguth D, Gonzalez-Granado LI, Alsina L, Querolt M, Griffin R, Hames C, Mondou E, Price J, Sanz A and Lin J.

    A Multi-Center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

    JOURNAL OF CLINICAL IMMUNOLOGY . 42(3): 500-511. Nº de citas: 5

    [doi:10.1007/s10875-021-01181-6]

  • Alsina L, Montoro JB, Moral PM, Neth O, Pica MO, Sánchez-Ramón S, Presa M, Oyagüez I, Casado MÁ and González-Granado LI.

    Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain

    EUROPEAN JOURNAL OF HEALTH ECONOMICS . 23(3): 551-558. Nº de citas: 13

    [doi:10.1007/s10198-021-01378-x]

  • Parrado A, Rubio G, Serrano M, De la Morena-Barrio ME, Ibáñez-Micó S, Ruiz-Lafuente N, Schwartz-Albiez R, Esteve-Solé A, Alsina L, Corral J and Hernández-Caselles T.

    Dissecting the transcriptional program of phosphomannomutase 2-deficient cells: Lymphoblastoide B cell lines as a valuable model for congenital disorders of glycosylation studies

    Glycobiology . 32(2): 84-100. Nº de citas: 4

    [doi:10.1093/glycob/cwab087]